日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of CD73 activity in breast cancer-derived small extracellular vesicles: application to monitoring of patients' responses to immunotherapy.

评估乳腺癌来源的小细胞外囊泡中 CD73 的活性:应用于监测患者对免疫疗法的反应

Whiteside T L, Sehra S, Chadderton T, Guha M, Stubbs M C, Timmers C, Jackson E K

Targeting CSPG4 for isolation of melanoma cell-derived exosomes from body fluids

靶向CSPG4从体液中分离黑色素瘤细胞来源的外泌体

Ferrone, S; Whiteside, T L

Exosomes carrying immunoinhibitory proteins and their role in cancer

携带免疫抑制蛋白的外泌体及其在癌症中的作用

Whiteside, T L

Phenotypic and functional characteristics of CD39(high) human regulatory B cells (Breg)

CD39(高表达)人类调节性B细胞(Breg)的表型和功能特征

Figueiró, F; Muller, L; Funk, S; Jackson, E K; Battastini, A M O; Whiteside, T L

The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg)

腺苷能通路在人类调节性T细胞(Treg)介导的免疫抑制中的作用

Whiteside, T L; Mandapathil, M; Schuler, P

Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.

HIV对患有丙型肝炎和血友病的男性肝纤维化的影响

Ragni M V, Moore C G, Soadwa K, Nalesnik M A, Zajko A B, Cortese-Hassett A, Whiteside T L, Hart S, Zeevi A, Li J, Shaikh O S

IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death

IRX-2 是一种新型免疫治疗药物,可保护人类 T 细胞免受肿瘤诱导的细胞死亡。

Czystowska, M; Han, J; Szczepanski, M J; Szajnik, M; Quadrini, K; Brandwein, H; Hadden, J W; Signorelli, K; Whiteside, T L

A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay

一种新型的多参数流式细胞术细胞毒性检测方法可同时对效应细胞进行免疫表型分析:与 4 小时 51Cr 释放试验的比较

Kim, G G; Donnenberg, V S; Donnenberg, A D; Gooding, W; Whiteside, T L

Reply: Controversies on autoimmunity and prognosis in cancer

回复:关于癌症自身免疫和预后的争议

Indolfi, Giuseppe; Bartolini, Elisa; Olivito, Biagio; Azzari, Chiara; Resti, Massimo; Whiteside, T L

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

头颈癌患者外周循环中CD4+CD25+调节性T细胞的特征

Schaefer, C; Kim, G G; Albers, A; Hoermann, K; Myers, E N; Whiteside, T L